MONROVIA, Calif.--(BUSINESS WIRE)--Xencor, Inc., a company developing protein and antibody therapeutics, will present new data from its pre-clinical CD19 program for lymphoma and leukemias at the Annual Meeting of the American Association for Cancer Research (AACR) being held at the San Diego Convention Center April 12-16, 2008.
